These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 31884406

  • 1. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
    Feng SL, Tian Y, Huo S, Qu B, Liu RM, Xu P, Li YZ, Xie Y.
    Phytomedicine; 2020 Feb; 67():153141. PubMed ID: 31884406
    [Abstract] [Full Text] [Related]

  • 2. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
    Liu RM, Xu P, Chen Q, Feng SL, Xie Y.
    Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
    [Abstract] [Full Text] [Related]

  • 3. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
    Mohammad IS, Teng C, Chaurasiya B, Yin L, Wu C, He W.
    Int J Pharm; 2019 Feb 25; 557():304-313. PubMed ID: 30599232
    [Abstract] [Full Text] [Related]

  • 4. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.
    Ma W, Feng S, Yao X, Yuan Z, Liu L, Xie Y.
    Sci Rep; 2015 Dec 22; 5():18789. PubMed ID: 26689156
    [Abstract] [Full Text] [Related]

  • 5. Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance.
    Li J, Zheng L, Wang R, Sun D, Liang S, Wu J, Liu Y, Tian X, Li T, Yang Y, Han L.
    Int J Nanomedicine; 2020 Dec 22; 15():5839-5853. PubMed ID: 32848393
    [Abstract] [Full Text] [Related]

  • 6. Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents.
    Feng S, Zhou H, Wu D, Zheng D, Qu B, Liu R, Zhang C, Li Z, Xie Y, Luo HB.
    Acta Pharm Sin B; 2020 Feb 22; 10(2):327-343. PubMed ID: 32082977
    [Abstract] [Full Text] [Related]

  • 7. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q, Song Y, Cheng X, Xu Z, Matthew OA, Wang J, Sun Z, Zhang X.
    Anticancer Res; 2019 Oct 22; 39(10):5461-5471. PubMed ID: 31570440
    [Abstract] [Full Text] [Related]

  • 8. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
    Wu ZL, Chen Y, Qu Z, Wu GY, He XF, Huang JW, Meng QQ, Hu YH, Shen XL, Yang RY, Hu YJ.
    J Ethnopharmacol; 2022 Aug 10; 294():115353. PubMed ID: 35533911
    [Abstract] [Full Text] [Related]

  • 9. Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.
    Guo X, To KKW, Chen Z, Wang X, Zhang J, Luo M, Wang F, Yan S, Fu L.
    J Exp Clin Cancer Res; 2018 Feb 20; 37(1):31. PubMed ID: 29458405
    [Abstract] [Full Text] [Related]

  • 10. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
    Jiang L, Wang P, Sun YJ, Wu YJ.
    J Exp Clin Cancer Res; 2019 Jun 18; 38(1):265. PubMed ID: 31215501
    [Abstract] [Full Text] [Related]

  • 11. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW.
    Cancer Res; 2008 Oct 01; 68(19):7905-14. PubMed ID: 18829547
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.
    Wang B, Li S, Meng X, Shang H, Guan Y.
    Tumour Biol; 2015 Aug 01; 36(8):6433-43. PubMed ID: 25801244
    [Abstract] [Full Text] [Related]

  • 13. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H, Hu B, He X, Mao J, Wang Y, Wang J, Zhang T, Zheng J, Peng Y, Zhang F.
    Biochem Pharmacol; 2020 Jan 01; 171():113733. PubMed ID: 31783010
    [Abstract] [Full Text] [Related]

  • 14. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X, He Y, Wei L, Zhang J, Li X, Cui W, Zhang S.
    J Pharm Pharmacol; 2021 Mar 08; 73(4):545-552. PubMed ID: 33793827
    [Abstract] [Full Text] [Related]

  • 15. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.
    Chen M, Song F, Liu Y, Tian J, Liu C, Li R, Zhang Q.
    Nanoscale; 2019 Mar 07; 11(9):3814-3826. PubMed ID: 30600823
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T, Anand U, Pandey SK, Ashby CR, Assaraf YG, Chen ZS, Dey A.
    Drug Resist Updat; 2021 Mar 07; 55():100754. PubMed ID: 33691261
    [Abstract] [Full Text] [Related]

  • 17. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L, Tian C, Chen D, Yuan Y, Yan Y, Huang Q, Zhang H, Zhang Z.
    Eur J Pharm Sci; 2019 Dec 01; 140():105071. PubMed ID: 31525433
    [Abstract] [Full Text] [Related]

  • 18. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells.
    Hyuga S, Shiraishi M, Hori A, Hyuga M, Hanawa T.
    Biol Pharm Bull; 2012 Dec 01; 35(10):1729-39. PubMed ID: 23037162
    [Abstract] [Full Text] [Related]

  • 19. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, Reznik SE, Chen ZS.
    Cancer Lett; 2019 Feb 01; 442():91-103. PubMed ID: 30391357
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X, Mo R, Ding Y, Zheng W, Zhang C.
    Mol Pharm; 2014 Jan 06; 11(1):145-57. PubMed ID: 24261922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.